Artiva Biotherapeutics ARTV
NASDAQ ARTV
$4.07 +0.01 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Artiva Biotherapeutics (ARTV) Common Stock Issued (2024 - 2026)

Updated

Artiva Biotherapeutics' Common Stock Issued came in at $138,000 for FY2025, down 99.9% from $166.56 million in FY2024.

Analysis

Artiva Biotherapeutics (ARTV) Common Stock Issued (2024 - 2026) Analysis & Trends

  • Per Business Quant, earlier years put Common Stock Issued at $166.56 million in FY2024 and $10,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Artiva Biotherapeutics 200.70 Mn -118.40 Mn - 270,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 270,000.00
Mar 31, 2025 138,000.00
Dec 31, 2024 23,000.00
Sep 30, 2024 166.51 Mn
API Access

Artiva Biotherapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ARTV&period=max&api_key=YOUR_API_KEY